Investors

b2venture

Founder-network VC with DACH bias; tags healthcare, biotech and medical, incl. preventative health.

Based in
St. Gallen, Switzerland
Type
VC
Stage
Pre-seed, Seed, Series A
Cheque size
€250k-€5m (average about €1m)
Backs
Fitness & movement, Sleep, recovery & longevity, Care & clinical
Business models
Consumer app or subscription, Consumer product, Physical sites
Recent deal
Amplifold (DNA-origami rapid diagnostic tests) seed, 2025; portfolio company Everlab raised AUD 65m Series A, June 2026 (b2venture role not stated)

Also backed

  • EverlabPreventative health and diagnostics clinic
  • NellyDigital medical practice workflow and payments
  • Urban Sports ClubFitness and wellbeing membership

Get the full investor map.

Every finder match and founder checklist, plus an Excel download. Free with Healthier Notes.

Unlock the map

Similar investors

Sources, checked October 2026
  1. b2venture.vc
  2. b2venture.vc